Latest stories on CRDL
Cardiol Therapeutics raises over US$7M through warrant exercises
Seeking Alpha59 · neutralgeneral
Cardiol Therapeutics receives over $7M in proceeds from warrant exercise
The Fly59 · neutralgeneral
Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds
PR Newswire59 · neutralgeneral
Cardiol Therapeutics: Q1 2027 Readout Will Be Make-Or-Break For Maveric
Seeking Alpha56 · neutralproduct/pr
Cardiol Therapeutics files $150M preliminary base shelf prospectus
The Fly24 · bearishgeneral
Cardiol Therapeutics files US$150M base shelf prospectus
Seeking Alpha28 · bearishgeneral
Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire56 · neutralgeneral
Cardiol Therapeutics initiated with a Buy at B. Riley
The Fly61 · neutralanalyst
B.Riley initiates Cardiol Therapeutics stock with buy rating on pericarditis drug potential
Investing.com Analyst Ratings61 · neutralanalyst
Cardiol Therapeutics price target raised to $10 from $8 at Canaccord
The Fly61 · neutralanalyst
Cardiol Therapeutics GAAP EPS of -C$0.05
Seeking Alpha34 · bearishearnings
Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 46th Annual Growth Conference
PR Newswire56 · neutralgeneral
Peer-Reviewed Phase II Results in JAHA Highlight CardiolRx’s Potential as MAVERIC Study Nears Completion
July 14, 2026
MarketChameleon73 · bullishproduct/pr
Cardiol Therapeutics' Phase II Recurrent Pericarditis Data Published in the Journal of the American Heart Association
PR Newswire67 · bullishproduct/pr
Cardiol Therapeutics to Highlight CardiolRx Programs at B. Riley Mind, Muscle & Vision Summit
TipRanks56 · neutralproduct/pr
Cardiol Therapeutics to Participate in Fireside Chat at B. Riley Securities Mind, Muscle & Vision Summit
PR Newswire56 · neutralgeneral
Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders
PR Newswire50 · neutralgeneral
Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association
PR Newswire67 · bullishproduct/pr